Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Angiology Open Access Journals

Vascular system in humans and animals is divided into the blood circulatory system, which contains the heart and blood vessels for the circulation of the bloodline and lymphatic system, consisting of lymph glands and lymphatic vessels, through which a colorless fluid, the lymph, circulates. Medical specialty which studies circulatory system, lymphatic system and their disease is called angiology. Open Access journals provides the online platform to the readers to access the articles without any financial barrier. Angiology Open Access Journal is the most cited journal which comprises the organized collection of original research articles, case reports, review articles and others. These articles are submitted by the authors throughout the world, which defines the diversity and variable scopes of the journal. Special issue initiated by the journal has the special attraction for the readers as it deals with the works related to a particular field of peripheral or cardiovascular diseases and diagnosis along with other blood vascular related disorders. OMICS Group International is a scientific organization that promotes open access for relevant scientific information and research findings and to date is dealing with around 700+ peer-reviewed journals. Angiology Open Access additionally distributes extraordinary issues and supplements identifying with particular themes of current enthusiasm to specialists and internists. OMICS Group simplifies the process of manuscript submission and its potential acceptance and approval for publication, through an efficient tracking system. Starting in 2007 with the Proteomics and Bioinformatics journal, the number of titles and published articles has grown steadily to reach a significant figure.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2024

Top